We’re delighted to announce the addition of Skysis, a boutique consulting firm providing integrated market access and commercial strategy solutions based in the US, to our group.
The company brings with it the ability to connect interdependencies across HCP, payer, channel, and patient stakeholders. It is the first acquisition with Fishawack Health’s new investor Bridgepoint.
The acquisition bolsters our strong consulting capabilities and furthers our skills in market access. Clients can benefit from these services across our three capabilities – marketing and commercial consulting, medical communications, and commercial and creative execution. Each of these services is underpinned shared world-class resources, including digital expertise, insight, data analytics and visualisation, and media and production.
These capabilities work independently or combine seamlessly as one unit, complete with teams tailored to the client’s individual needs and challenges. As a result, our clients can utilise Skysis’ skills in combination with a wide range of services.
Oliver Dennis, Fishawack Health co-founder and CEO, said: “In partnering with Bridgepoint, we have made a step-change in our ambition. We’re delighted today to add Skysis to the group. They bring strategy and market access across the entire commercial life cycle, making them an important addition to our strategic consulting capabilities.”
Fred Bassett, Head of Consulting for Fishawack Health, added: “Skysis provides strategy and execution across every stage of the commercial life cycle. The company’s expertise bolsters Fishawack Health’s strong strategic consulting team, which includes analysts, researchers, commercial consultants, market access and customer experience specialists, and boasts a network of Physician Expert Partnerships.”
Providing further detail, Dan Twibell Managing Director of Skysis, explained: “We wanted to partner with a group that could help us scale our business, offer more solutions to our clients and that our team would be excited to join.”
Dawn Rich, Managing Director of Skysis, said: “Our team is thrilled to be joining Fishawack Health. Our core capabilities match perfectly with the key services of the wider consulting capability.”
Our strategic and scientific focus makes it ideally placed to solve complex brand, portfolio and enterprise-level challenges for its clients. With experience across every major therapeutic category, we understand what it takes to improve patient outcomes and drive business success. We will continue to add new capabilities designed to solve our client’s critical medical and commercial challenges in an integrated and seamless way.
Please contact us to find out how we can help you solve your healthcare challenges.